Founder effect

Revision as of 04:54, 21 August 2013 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Founder effect

Articles

Most recent articles on Founder effect

Most cited articles on Founder effect

Review articles on Founder effect

Articles on Founder effect in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Founder effect

Images of Founder effect

Photos of Founder effect

Podcasts & MP3s on Founder effect

Videos on Founder effect

Evidence Based Medicine

Cochrane Collaboration on Founder effect

Bandolier on Founder effect

TRIP on Founder effect

Clinical Trials

Ongoing Trials on Founder effect at Clinical Trials.gov

Trial results on Founder effect

Clinical Trials on Founder effect at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Founder effect

NICE Guidance on Founder effect

NHS PRODIGY Guidance

FDA on Founder effect

CDC on Founder effect

Books

Books on Founder effect

News

Founder effect in the news

Be alerted to news on Founder effect

News trends on Founder effect

Commentary

Blogs on Founder effect

Definitions

Definitions of Founder effect

Patient Resources / Community

Patient resources on Founder effect

Discussion groups on Founder effect

Patient Handouts on Founder effect

Directions to Hospitals Treating Founder effect

Risk calculators and risk factors for Founder effect

Healthcare Provider Resources

Symptoms of Founder effect

Causes & Risk Factors for Founder effect

Diagnostic studies for Founder effect

Treatment of Founder effect

Continuing Medical Education (CME)

CME Programs on Founder effect

International

Founder effect en Espanol

Founder effect en Francais

Business

Founder effect in the Marketplace

Patents on Founder effect

Experimental / Informatics

List of terms related to Founder effect

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The founder effect was defined by Ernst Mayr in 1963 to be the effect of establishing a new population by a small number of individuals, carrying only a small fraction of the original population's genetic variation. As a result, the new population may be distinctively different, both genetically and phenotypically, from the parent population from which it is derived. In extreme cases, the founder effect is thought to lead to the speciation and subsequent evolution of new species. The founder effect is a feature that can also occur in memetic evolution.

In the figure shown, the original population has nearly equal numbers of blue and red individuals. The three smaller founder populations show that one or the other color may predominate (founder effect), due to random sampling of the original population. A population bottleneck may also cause a founder effect even though it is not strictly a new population.

In addition to founder effects, the new population is often a very small population and so shows increased sensitivity to genetic drift, an increase in inbreeding, and relatively low genetic variation. This can be observed in the limited gene pool of Easter Islanders and those native to Pitcairn Island.

Founder effects in island ecology

Founder populations are essential to the study of island biogeography and island ecology. A natural tabula rasa is not easily found, but a classic series of studies on founder population effects were done following the catastrophic 1883 eruption of Krakatau (Krakatoa), which erased all life on the island remnant. Another continuing study has been following the biocolonization of Surtsey, Iceland, a new volcanic island that erupted offshore between 1963 and 1967. An earlier event, the Toba eruption in Sumatra of about 73,000 YBP, covered some parts of India with 3–6 m of ash, and must have coated the Nicobar Islands and Andaman Islands, much nearer in the ash fallout cone, with life-smothering layers, restarting their biodiversity from effectively zero.

Founder effects in human populations

Due to various migrations throughout human history, founder effects are somewhat common among humans in different times and places. The effective founder population of Quebec was only 2,600. After twelve to sixteen generations, with an eighty-fold growth but minimal gene dilution from intermarriage, Quebec has what geneticists call optimal linkage disequilibrium (genetic sharing).[1] The result: far fewer genetic variations, including those that have been well studied because they are connected with inheritable diseases.

Founder effects can also occur naturally as competing genetic lines die out. This means that an effective founder population consists only of those whose genetic print is identifiable in subsequent populations. Because in sexual reproduction, genetic recombination ensures that with each generation only half the genetic material of a parent is represented in the offspring, some genetic lines may die out entirely, even though there are numerous progeny. A recent study[2] concluded that of the people migrating across the Bering land bridge at the close of the ice age, only 70 left their genetic print in modern descendants, a minute effective founder population— which is easily misread as though implying that only 70 people crossed to North America. The misinterpretations of "Mitochondrial Eve" are a case in point: it may be hard to explain that a "mitochondrial Eve" was not the only woman of her time.

In humans, founder effects can arise from cultural isolation, and inevitably, endogamy. For example, the Amish populations in the United States, which have grown from a very few founders, have not recruited newcomers, and tend to marry within the community, exhibit founder effects. Though still rare absolutely, phenomena such as polydactyly (extra fingers and toes, a symptom of Ellis-van Creveld syndrome) are more common in Amish communities than in the US population at large.[3] Similar religious and cultural founder effects have been demonstrated through the prevalence of otherwise rare diseases among South African Muslims, among whom cleidocranial dysostosis is more common (due to one founder who was a Chinese immigrant who converted to Islam)[citation needed]. There is also the presence of high cases of fumarase deficiency among the 10,000 members of the Fundamentalist Church of Jesus Christ of Latter Day Saints community, a breakaway sect which practices both endogamy and polygamy, where it is estimated 75 to 80 percent of the community are blood relatives of just two men - founders John Y. Barlow and Joseph Smith Jessop.[4]

See also

References

  1. genizon.com
  2. Hey, Jody, 2005. "On the Number of New World Founders: A Population Genetic Portrait of the Peopling of the Americas" in PLoS Biol 2005 May 24;3(6):e193 webpage
  3. McKusick, V. A.; Egeland, J. A.; Eldridge, R.; Krusen, D. E.: Dwarfism in the Amish. I. The Ellis-van Creveld syndrome. Bull. Johns Hopkins Hosp. 115: 306-336, 1964. PMID 14217223
  4. boston.com
  • Mayr, E. 1963. Animal Species and Evolution. Harvard University Press, Cambridge, Massachusetts.

External links

Template:Popgen